TIAA Trust, National Association’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-3,478
Closed -$587K – 521
2025
Q4
$587K Buy
3,478
+10
+0.3% +$1.62K ﹤0.01% 462
2025
Q3
$501K Sell
3,468
-18
-0.5% -$2.46K ﹤0.01% 486
2025
Q2
$441K Buy
3,486
+153
+5% +$18.8K ﹤0.01% 478
2025
Q1
$426K Buy
3,333
+179
+6% +$24.3K ﹤0.01% 468
2024
Q4
$417K Buy
3,154
+787
+33% +$111K ﹤0.01% 472
2024
Q3
$345K Buy
2,367
+38
+2% +$5.5K ﹤0.01% 513
2024
Q2
$320K Sell
2,329
-123
-5% -$16.4K ﹤0.01% 503
2024
Q1
$336K Buy
2,452
+14
+0.6% +$1.91K ﹤0.01% 493
2023
Q4
$331K Hold
2,438
– – ﹤0.01% 474
2023
Q3
$298K Buy
+2,438
New +$310K ﹤0.01% 484

Other funds holding IBB

TIAA Trust, National Association's IBB Position: Q1 2026 in Review

TIAA Trust, National Association sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 3,478 shares — an estimated $587K sold.

TIAA Trust, National Association first reported a position in IBB in Q3 2023 and held it in 10 quarters. The position peaked at $587K in Q4 2025. 924 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • TIAA Trust, National Association reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • TIAA Trust, National Association sold 3,478 iShares Biotechnology ETF shares in Q1 2026, an estimated $587K.
  • TIAA Trust, National Association first reported a position in iShares Biotechnology ETF in Q3 2023 and held it in 10 quarters.
  • TIAA Trust, National Association's iShares Biotechnology ETF position peaked at $587K in Q4 2025.
  • 924 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on TIAA Trust, National Association's 13F filing for Q1 2026, filed 12 May 2026.